Section one: Contracting authority
one.1) Name and addresses
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Nobel House, 17 Smith Square
London
SW1P 3JR
Country
United Kingdom
NUTS code
UKI32 - Westminster
Internet address(es)
Main address
https://www.gov.uk/government/organisations/uk-health-security-agency
Buyer's address
https://www.gov.uk/government/organisations/uk-health-security-agency
one.2) Information about joint procurement
The contract is awarded by a central purchasing body
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
MenACWY Vaccine
Reference number
CM/PHV/23/15697
two.1.2) Main CPV code
- 33651600 - Vaccines
two.1.3) Type of contract
Supplies
two.1.4) Short description
Provision for the supply of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y (MenACWY)
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £1
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
To a location in England to be notified to the successful bidder(s) following contract award.
two.2.4) Description of the procurement
The provision of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national childhood immunisation programme.
The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to
4.7 million doses of vaccine.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
two.2.5) Award criteria
Quality criterion - Name: Comparison with specification / Weighting: 40
Quality criterion - Name: Risk to programme delivery / Weighting: 20
Quality criterion - Name: Social value / Weighting: 10
Cost criterion - Name: Price / Weighting: 30
two.2.11) Information about options
Options: Yes
Description of options
This contract has the option to be extended for a period or periods up to an additional 24 months
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2022/S 000-003761
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
18 July 2022
five.2.2) Information about tenders
Number of tenders received: 3
Number of tenders received from SMEs: 0
Number of tenders received by electronic means: 3
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Aventis Pharma Ltd Trading As Sanofi
410 Thames Valley Park Drive
Reading
RG6 1PT
Country
United Kingdom
NUTS code
- UK - United Kingdom
National registration number
01535640
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £1
Total value of the contract/lot: £1
Section six. Complementary information
six.3) Additional information
The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
six.4) Procedures for review
six.4.1) Review body
The High Court
Strand
London
WC2A 2LL
generaloffice@administrativecourtoffice.justice.gov.uk
Country
United Kingdom